Challenges and prospects of visual contactless physiological monitoring in clinical study
The monitoring of physiological parameters is a crucial topic in promoting human health and
an indispensable approach for assessing physiological status and diagnosing diseases …
an indispensable approach for assessing physiological status and diagnosing diseases …
[HTML][HTML] Facilitators of and barriers to accessing hospital medical specialty telemedicine consultations during the COVID-19 pandemic: systematic review
AS Cunha, AR Pedro, JV Cordeiro - Journal of medical Internet research, 2023 - jmir.org
Background The COVID-19 pandemic accelerated the digital transition in health care, which
required a rapid adaptation for stakeholders. Telemedicine has emerged as an ideal tool to …
required a rapid adaptation for stakeholders. Telemedicine has emerged as an ideal tool to …
[HTML][HTML] Evaluating a remote monitoring program for respiratory diseases: prospective observational study
Background Patients with chronic respiratory diseases and those in the postdischarge
period following hospitalization because of COVID-19 are particularly vulnerable, and little is …
period following hospitalization because of COVID-19 are particularly vulnerable, and little is …
[HTML][HTML] Clinicians' experiences of implementing a telerehabilitation toolkit during the COVID-19 pandemic: qualitative descriptive study
Background Although the COVID-19 pandemic resulted in a rapid implementation and scale-
up of telehealth for patients in need of rehabilitation, an overall slower scaling up to …
up of telehealth for patients in need of rehabilitation, an overall slower scaling up to …
Clinical Guidance on the monitoring and management of Trastuzumab Deruxtecan (T-DXd)-Related adverse events: insights from an Asia-Pacific Multidisciplinary …
JWY Chiu, SC Lee, JC Ho, YH Park, TC Chao, SB Kim… - Drug Safety, 2023 - Springer
Abstract Trastuzumab deruxtecan (T-DXd)—an antibody–drug conjugate targeting the
human epidermal growth factor receptor 2 (HER2)—improved outcomes of patients with …
human epidermal growth factor receptor 2 (HER2)—improved outcomes of patients with …
Immune checkpoint inhibitor-related pneumonitis: research advances in prediction and management
MX Lin, D Zang, CG Liu, X Han, J Chen - Frontiers in Immunology, 2024 - frontiersin.org
The advent of immune-checkpoint inhibitors (ICIs) has revolutionized the treatment of
malignant solid tumors in the last decade, producing lasting benefits in a subset of patients …
malignant solid tumors in the last decade, producing lasting benefits in a subset of patients …
PACMAN: A framework for pulse oximeter digit detection and reading in a low-resource setting
C Boonnag, P Ittichaiwong… - IEEE Internet of …, 2023 - ieeexplore.ieee.org
In light of the COVID-19 pandemic, patients were required to manually input their daily
oxygen saturation (SpO 2) and pulse rate (PR) values into a health monitoring system …
oxygen saturation (SpO 2) and pulse rate (PR) values into a health monitoring system …
Transition of care interventions to manage severe COVID-19 in the ambulatory setting: a systematic review
Background Severe COVID-19, with the need in supplemental oxygen and hospitalization,
leads to major burden on patients and healthcare systems. As a result, safe and effective …
leads to major burden on patients and healthcare systems. As a result, safe and effective …
Beyond the Pain Management Clinic: The Role of AI-Integrated Remote Patient Monitoring in Chronic Disease Management–A Narrative Review
PM Patel, M Green, J Tram, E Wang… - Journal of Pain …, 2024 - Taylor & Francis
Abstract Remote Patient Monitoring (RPM) stands as a pivotal advancement in patient-
centered care, offering substantial improvements in the diagnosis, management, and …
centered care, offering substantial improvements in the diagnosis, management, and …
The effects of primary care monitoring strategies on COVID-19 related hospitalisation and mortality: a retrospective electronic medical records review in a northern …
Abstract Background Most symptomatic SARS-CoV-2 infections produce mild to moderate
symptoms. Although most patients are managed in the outpatient setting, little is known …
symptoms. Although most patients are managed in the outpatient setting, little is known …